Infarction Prevention
Investigators at University Hospital publish new data on infarction prevention
Published in Hospital Law Weekly, March 25th, 2010
Investigators publish new data in the report 'Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events).' According to recent research from Paris, France, "The aim of this study was to assess the risk-benefit of enoxaparin (Sanofi-Aventis, Paris, France) in primary percutaneous coronary intervention (PCI). Randomized studies have demonstrated the superiority of enoxaparin over unfractionated heparin (UFH) in acute ST-segment elevation myocardial infarction (STEMI) treated with fibrinolytics."
"In the FINESSE...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2010-03-25)
More Articles from Hospital Law Weekly
- Citizens Against Government Waste CAGW
CAGW Applauds President's Support for Medicare Fraud "Bounty Hunters" - Clinical Practice
Scientists at Uppsala University publish research in clinical practice - Epidemics
Studies from Hadassah Hebrew University describe new findings in epidemics - Health Insurance
Ama Study Shows Competition Disappearing In the Health Insurance Industry - Life Sciences
St. Mary's Hospital Emerges From Chapter 11 Reinvigorated - NIH/National Institutes of Health, Office of Disease Prevention
Panel questions 'VBAC bans,' advocates expanded delivery options for women - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
